These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 15986332
1. Comparative proteomic analysis of esophageal squamous cell carcinoma. Qi Y, Chiu JF, Wang L, Kwong DL, He QY. Proteomics; 2005 Jul; 5(11):2960-71. PubMed ID: 15986332 [Abstract] [Full Text] [Related]
2. Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC. Hu YC, Lam KY, Law S, Wong J, Srivastava G. Clin Cancer Res; 2001 Nov; 7(11):3519-25. PubMed ID: 11705871 [Abstract] [Full Text] [Related]
6. [Expression and significance of heat shock proteins in esophageal squamous cell carcinoma]. Chen JH, Chen LM, Xu LY, Wu MY, Shen ZY. Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):758-61. PubMed ID: 17366788 [Abstract] [Full Text] [Related]
7. Up-regulated manganese superoxide dismutase expression increases apoptosis resistance in human esophageal squamous cell carcinomas. Hu H, Luo ML, Du XL, Feng YB, Zhang Y, Shen XM, Xu X, Cai Y, Han YL, Wang MR. Chin Med J (Engl); 2007 Dec 05; 120(23):2092-8. PubMed ID: 18167182 [Abstract] [Full Text] [Related]
10. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma. Sakai M, Kato H, Sano A, Tanaka N, Inose T, Kimura H, Sohda M, Nakajima M, Kuwano H. Ann Surg Oncol; 2009 Sep 05; 16(9):2494-501. PubMed ID: 19526206 [Abstract] [Full Text] [Related]
11. Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma. Gu ZD, Li JY, Li M, Gu J, Shi XT, Ke Y, Chen KN. Am J Gastroenterol; 2005 Aug 05; 100(8):1835-43. PubMed ID: 16086722 [Abstract] [Full Text] [Related]
12. Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma. Faried A, Faried LS, Usman N, Kato H, Kuwano H. Ann Surg Oncol; 2007 Dec 05; 14(12):3593-601. PubMed ID: 17896152 [Abstract] [Full Text] [Related]
13. Over-expression of gastrin-releasing peptide in human esophageal squamous cell carcinomas. Fang MZ, Liu C, Song Y, Yang GY, Nie Y, Liao J, Zhao X, Shimada Y, Wang LD, Yang CS. Carcinogenesis; 2004 Jun 05; 25(6):865-71. PubMed ID: 14764456 [Abstract] [Full Text] [Related]
17. Expression of 11 HOX genes is deregulated in esophageal squamous cell carcinoma. Chen KN, Gu ZD, Ke Y, Li JY, Shi XT, Xu GW. Clin Cancer Res; 2005 Feb 01; 11(3):1044-9. PubMed ID: 15709170 [Abstract] [Full Text] [Related]
18. Decreased expression of RUNX3 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma. Sugiura H, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, Mori Y, Ogawa R, Katada T, Harata K, Fujii Y. Oncol Rep; 2008 Mar 01; 19(3):713-9. PubMed ID: 18288406 [Abstract] [Full Text] [Related]
19. The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma. Ando T, Ishiguro H, Kimura M, Mitsui A, Mori Y, Sugito N, Tomoda K, Mori R, Harada K, Katada T, Ogawa R, Fujii Y, Kuwabara Y. Oncol Rep; 2007 Sep 01; 18(3):601-9. PubMed ID: 17671707 [Abstract] [Full Text] [Related]
20. Comparative proteomic analysis of beta-catenin-mediated malignant progression of esophageal squamous cell carcinoma. Ren HZ, Wang JS, Pan GQ, Lv H, Wen JF, Luo GQ, Wang KS, Zhang PF. Dis Esophagus; 2010 Feb 01; 23(2):175-84. PubMed ID: 19664078 [Abstract] [Full Text] [Related] Page: [Next] [New Search]